Publication | Closed Access

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1

Insulin ResistanceIl28b PolymorphismHepatologyAutoimmune DiseaseViral HepatitisDiabetesImmunologyAntiviral TherapyHepatitisAutoimmunityLiver DiseaseChronic Viral InfectionMedicineImmune-related Gene PolymorphismAutoimmune Liver DiseaseGenotype 1